Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](ACADIA Pharmaceuticals Inc.)"
Count: 40
Selected: 0
NCT IDTitle
NCT05555615Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
NCT05523895Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
NCT05008835Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee
NCT04988867An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
NCT04855240Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy
NCT04776746Open-Label Extension Study of Trofinetide for Rett Syndrome
NCT04531982Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
NCT04292223Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
NCT04279314Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
NCT04181723Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
NCT04164758Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
NCT04000009Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
NCT03968159Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
NCT03623321Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
NCT03575052A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
NCT03482882Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression
NCT03325556Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
NCT03152292The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study
NCT03121586Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
NCT03118947A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease
NCT03018340Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
NCT02992132Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
NCT02970305Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)
NCT02970292Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
NCT02762591Expanded Access of Pimavanserin for Patients With PD Psychosis
NCT02035553A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
NCT01518309An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
NCT01174004A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
NCT00658567A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
NCT00550238A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
NCT00490516ACP-104 in Acutely Psychotic Subjects With Schizophrenia
NCT00477672A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
NCT00361166Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
NCT00087542Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug
NCT04809116Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
NCT05441280Pimavanserin for Insomnia in Veterans With PTSD
NCT05357612Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
NCT05240339Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)
NCT00628420Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics
NCT03994965The Sub-Sero Study